Overestimated lead times in cancer screening has led to substantial underestimation of overdiagnosis

BACKGROUND: Published lead time estimates in breast cancer screening vary from 1 to 7 years and the percentages of overdiagnosis vary from 0 to 75%. The differences are usually explained as random variations. We study how much can be explained by using different definitions and methods. METHODS: We...

Descripción completa

Detalles Bibliográficos
Autores principales: Zahl, P-H, Jørgensen, K J, Gøtzsche, P C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3790152/
https://www.ncbi.nlm.nih.gov/pubmed/23963144
http://dx.doi.org/10.1038/bjc.2013.427

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3790152/
https://www.ncbi.nlm.nih.gov/pubmed/23963144
http://dx.doi.org/10.1038/bjc.2013.427

Ejemplares similares